Skip to content

Direct Resuscitation of the Open Peritoneum

Direct Resuscitation of the Open Peritoneum: A Randomized Controlled Trial in Non-Traumatic Patients

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04887480
Acronym
SH DROP
Enrollment
200
Registered
2021-05-14
Start date
2021-05-14
Completion date
2026-05-30
Last updated
2024-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdomen, Acute, Wound; Abdomen, Wound Surgical

Brief summary

The DROP trial evaluates two ways of treating patients whose abdomens are left open after their abdominal surgery. The current standard of care at Sanford is for patients to have their wound covered with a sterile dressing connected to a vacuum with suction, which removes fluid from the abdomen. In this trial, we are evaluating the benefits of adding dialysis fluid to the abdomen periodically, prior to suctioning it out with the vacuum system. This trial will show if the addition of this fluid lowers the risk of complications and death, and allows the surgeon to close the abdomen sooner

Interventions

DEVICEAbthera™ Open Abdomen Negative Pressure Therapy Device System

Suction set at -125mmHg

DRUGDianeal PD-2 with 2.5% Dextrose

800mL to 1000mL of Dianeal PD-2 into Abthera™ and dwell for 1 hour.

Sponsors

Sanford Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥18 years of age * Have index operation performed by one of the Trauma and Acute Care surgeons at Sanford Medical Center Fargo * Require an open abdomen due to a non-traumatic cause and placement of an Abthera™ wound vacuum * Cognitively impaired adults will be included if a Legally Authorized Representative is available to provide informed consent.

Exclusion criteria

* Patients under the age of 18 * Vulnerable populations such as pregnant women and prisoners * Patients with open abdomens as the result of trauma * Non-English speaking (Due to time constraints pre-operatively and the length of time necessary to secure translation services, non-English speaking patients will not be enrolled).

Design outcomes

Primary

MeasureTime frameDescription
Major ComplicationsThrough study completion, an average of 6 monthsMajor complications (yes/no). Major complications include intra-abdominal abscess, wound dehiscence, anastomotic leak, intra-abdominal bleed, biloma, enterocutaneous fistula, evisceration, acute respiratory distress syndrome (ARDS)
Number of operations and time to closureup to 4 weekshow many procedures/how long did it take to close the abdomen

Secondary

MeasureTime frameDescription
Length of ICU Stayup to 4 weeksHow many days was patient in ICU
Time on Vasopressorsup to 4 weeksHow many days was patient on vasopressors

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026